跳至主要内容
临床试验/DRKS00029542
DRKS00029542已完成不适用

Outcome of pediatric oncology patients with febrile neutropenia after introduction of a standard operating procedure for time-to-antibiotic therapy in a children's cancer center - TTA in F

Zentrum für Kinder- und Jugendmedizin des Universitätsklinikums Freiburg,Klink für pädiatrische Hämatologie und Onkologie0 个研究点目标入组 117 人开始时间: 2022年7月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
117

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 18 Years(—)
性别
All

入选标准

  • Pediatric oncology patients treated by home or external clinic/physician without prior treatment with fever in neutropenia (ANC <500) and/or in reduced general condition and/or with clinical signs of SIRS after chemotherapy in the pediatric emergency department or in the Oncology Outpatient Clinic of the Center for Pediatric and Adolescent Medicine from May 2019 to May 2021 and then admitted as inpatients
  • Consent for inclusion in the Hilda Biobank with use of linked clinical data.

排除标准

  • Patients with prior antibiotic treatment, fever without neutropenia or without change in general condition or signs of SIRS.
  • Lack of consent for inclusion in the Hilda Biobank.

研究者

发起方
Zentrum für Kinder- und Jugendmedizin des Universitätsklinikums Freiburg,Klink für pädiatrische Hämatologie und Onkologie

相似试验